Mass spectrometric protein maps for biomarker discovery and clinical research

Expert Review of Molecular Diagnostics

Volumn 13, Issue 8, 2013, Pages 811-825

  Liu, Yansheng ^a   Hüttenhain, Ruth ^a   Collins, Ben ^a   Aebersold, Ruedi ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

biomarker discovery; diagnostics; digital maps; mass spectrometry; proteomics; reference maps; selected reaction monitoring; SWATH MS

Indexed keywords

CLINICAL RESEARCH; MASS SPECTROMETRY; PERSONALIZED MEDICINE; PROTEOMICS; REVIEW; WORKFLOW;

AMINO ACID SEQUENCE; DATABASES, PROTEIN; HUMANS; MASS SPECTROMETRY; NEOPLASMS; PROTEOME; REFERENCE STANDARDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887359663     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.845089     Document Type: Review

References (100)

1. Etzioni R, Urban N, Ramsey S et al. The case for early detection. Nat. Rev. Cancer 3(4), 243-252 (2003
2. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol. 24(8), 971-983 (2006
3. Sawyers CL. The cancer biomarker problem. Nature 452(7187), 548-552 (2008
4. Sobin LH. TNM: Evolution and relation to other prognostic factors. Semin. Surg. Oncol. 21(1), 3-7 (2003
5. Hamburg MA, Collins FS. The path to personalized medicine. N. Engl. J. Med. 363(4), 301-304 (2010
6. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R. Perspective: A program to improve protein biomarker discovery for cancer. J. Proteome Res. 4(4), 1104-1109 (2005
7. Domon B, Aebersold R. Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28(7), 710-721 (2010
8. Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions. Nat. Methods 9(6), 555-566 (2012
9. Picotti P, Bodenmiller B, Aebersold R. Proteomics meets the scientific method. Nat. Methods 10(1), 24-27 (2013
10. Huttenhain R, Soste M, Selevsek N et al. Reproducible quantification of cancer-Associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4(142), 142-194 (2012
11. Kalin M, Cima I, Schiess R et al. Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur. Urol. 60(6), 1235-1243 (2011
12. Cima I, Schiess R, Wild P et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl Acad. Sci. USA 108(8), 3342-3347 (2011
13. Gillet LC, Navarro P, Tate S et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11(6), O111 016717 (2012
14. Reiter L, Rinner O, Picotti P et al. mProphet: Automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8(5), 430-435 (2011
15. Diamandis EP. The failure of protein cancer biomarkers to reach the clinic: Why, and what can be done to address the problem? BMC Med. 10, 87 (2012
16. Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27(7), 633-641 (2009
17. Roobol MJ, Carlsson SV. Risk stratification in prostate cancer screening. Nat. Rev. Urol. 10(1), 38-48 (2013
18. Karam AK, Karlan BY. Ovarian cancer: The duplicity of CA125 measurement. Nat. Rev. Clin. Oncol. 7(6), 335-339 (2010
19. Del Mastro L, Lambertini M, Bighin C et al. Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. Expert Rev. Anticancer Ther. 12(11), 1391-1405 (2012
20. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 312(5771), 212-217 (2006
21. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 422(6928), 198-207 (2003
22. Sabido E, Selevsek N, Aebersold R. Mass spectrometry-based proteomics for systems biology. Curr. Opin. Biotechnol. 23(4), 591-597 (2012
23. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4(3), 207-214 (2007
24. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnology 26(12), 1367-1372 (2008
25. Tabb DL, Vega-Montoto L, Rudnick PA et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-Tandem mass spectrometry. J. Proteome Res. 9(2), 761-776 (2010
26. Kim YJ, Feild B, Fitzhugh W et al. Reference map for liquid chromatography-mass spectrometry-based quantitative proteomics. Anal Biochem. 393(2), 155-162 (2009
27. Schmidt A, Gehlenborg N, Bodenmiller B et al. An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures. Mol. Cell. Proteomics 7(11), 2138-2150 (2008
28. Jaffe JD, Keshishian H, Chang B, Addona TA, Gillette MA, Carr SA. Accurate inclusion mass screening: A bridge from unbiased discovery to targeted assay development for biomarker verification. Mol. Cell. Proteomics 7(10), 1952-1962 (2008
29. Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11(11), 1475-1488 (2012
30. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: A tutorial. Mol. Syst. Biol. 4, 222 (2008
31. Nilsson T, Mann M, Aebersold R, Yates Jr. 3rd, Bairoch A, Bergeron JJ. Mass spectrometry in high-Throughput proteomics: Ready for the big time. Nat. Methods 7(9), 681-685 (2010
32. Lam H, Deutsch EW, Eddes JS, Eng JK, Stein SE, Aebersold R. Building consensus spectral libraries for peptide identification in proteomics. Nat. Methods 5(10), 873-875 (2008
33. Lam H, Aebersold R. Spectral library searching for peptide identification via tandem MS. Methods Mol. Biol. 604, 95-103 (2010
34. Lam H, Deutsch EW, Eddes JS et al Development and validation of a spectral library searching method for peptide identification from MS/MS. Proteomics 7(5), 655-667 (2007
35. Picotti P, Clement-Ziza M, Lam H et al. A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis. Nature 494(7436), 266-270 (2013
36. Deutsch EW, Lam H, Aebersold R. PeptideAtlas: A resource for target selection for emerging targeted proteomics workflows. EMBO Rep. 9(5), 429-434 (2008
37. Frank R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 267(1), 13-26 (2002
38. Picotti P, Rinner O, Stallmach R et al. High-Throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat. Methods 7(1), 43-46 (2010
39. Ahrens CH, Brunner E, Qeli E, Basler K, Aebersold R. Generating and navigating proteome maps using mass spectrometry. Nat. Rev. Mol. Cell Biol. 11(11), 789-801 (2010
40. Karlsson C, Malmstrom L, Aebersold R, Malmstrom J. Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat. Commun. 3, 1301 (2012
41. Schubert OT, Mouritsen J, Ludwig C et al. The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis. Cell Host Microbe 13(5), 602-612 (2013
42. Desiere F, Deutsch EW, King NL et al. The PeptideAtlas project. Nucleic Acids Res. 34(Database issue), D655-D658 (2006
43. Mathivanan S, Ahmed M, Ahn NG et al. Human Proteinpedia enables sharing of human protein data. Nat. Biotechnol. 26(2), 164-167 (2008
44. Craig R, Cortens JP, Beavis RC. Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 3(6), 1234-1242 (2004
45. Jones P, Cote RG, Cho SY et al. PRIDE: New developments and new datasets. Nucleic Acids Res. 36(Database issue), D878-D883 (2008
46. Farrah T, Deutsch EW, Kreisberg R et al. PASSEL: The Pepti deAtlas SRM experiment library. Proteomics 12(8), 1170-1175 (2012
47. Zhang H, Liu AY, Loriaux P et al. Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6(1), 64-71 (2007
48. Anderson NL, Anderson NG. The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 1(11), 845-867 (2002
49. States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol 24(3), 333-338 (2006
50. Farrah T, Deutsch EW, Omenn GS et al. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 10(9), M110 006353 (2011
51. Taussig MJ, Stoevesandt O, Borrebaeck CA et al. ProteomeBinders: Planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 4(1), 13-17 (2007
52. Lundberg E, Fagerberg L, Klevebring D et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 6, 450 (2010
53. Mann M, Kulak NA, Nagaraj N, Cox J. The coming age of complete, accurate, and ubiquitous proteomes. Mol. Cell 49(4), 583-590 (2013
54. Nagaraj N, Wisniewski JR, Geiger T et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011
55. Beck M, Schmidt A, Malmstroem J et al. The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549 (2011
56. Wisniewski JR, Ostasiewicz P, Dus K, Zielinska DF, Gnad F, Mann M. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611 (2012
57. Fagerberg L, Oksvold P, Skogs M et al. Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP). J. Proteome Res. (2012
58. Farrah T, Deutsch EW, Hoopmann MR et al. The state of the human proteome in 2012 as viewed through PeptideAtlas. J. Proteome Res. 12(1), 162-171 (2013
59. Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomarker insights 1, 1-48 (2007
60. Wollscheid B, Bausch-Fluck D, Henderson C et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 27(4), 378-386 (2009
61. Roth J. Protein N-glycosylation along the secretory pathway: Relationship to organelle topography and function, protein quality control, and cell interactions. Chem. Rev. 102(2), 285-303 (2002
62. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 3(1), 33-44 (2009
63. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21(6), 660-666 (2003
64. Zielinska DF, Gnad F, Wisniewski JR, Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141(5), 897-907 (2010
65. Tian Y, Bova GS, Zhang H. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal Chem. 83(18), 7013-7019 (2011
66. Chen R, Tan Y, Wang M et al. Development of glycoprotein capture-based label-free method for the high-Throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol. Cell. Proteomics 10(7), M110 006445 (2011
67. Zeng X, Hood BL, Sun M et al. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 9(12), 6440-6449 (2010
68. Huttenhain R, Surinova S, Ossola R et al. N-Glycoprotein SRMAtlas: A resource of mass-spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol. Cell. Proteomics 12(4), 1005-1016 (2013
69. Michalski A, Damoc E, Lange O et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 11(3), O111 013698 (2012
70. Cristobal A, Hennrich ML, Giansanti P, Goerdayal SS, Heck AJ, Mohammed S. In-house construction of a UHPLC system enabling the identification of over 4000 protein groups in a single analysis. Analyst 137(15), 3541-3548 (2012
71. Wu L, Han DK. Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics. Expert Rev. Proteomics 3(6), 611-619 (2006
72. Schmidt A, Claassen M, Aebersold R. Directed mass spectrometry: Towards hypothesis-driven proteomics. Curr. Opin. Chem. Biol. 13(5-6), 510-517 (2009
73. Liu YS, Luo XY, Li QR et al. Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancer. J. Mol. Cell Biol. 4(5), 344-347 (2012
74. Kuzyk MA, Smith D, Yang J et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cellular Proteomics 8(8), 1860-1877 (2009
75. Surinova S, Schiess R, Huttenhain R, Cerciello F, Wollscheid B, Aebersold R. On the development of plasma protein biomarkers. J. Proteome Res. 10(1), 5-16 (2011
76. Huttenhain R, Malmstrom J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Current Opin. Chem. Biol. 13(5-6), 518-525 (2009
77. Stahl-Zeng J, Lange V, Ossola R et al. High sensitivity detection of plasma proteins by multiple reaction monitoring of Nglycosites. Mol. Cell. Proteomics 6(10), 1809-1817 (2007
78. Selevsek N, Matondo M, Sanchez Carbayo M, Aebersold R, Domon B. Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics 11(6), 1135-1147 (2011
79. Ebhardt HA, Sabido E, Huttenhain R, Collins B, Aebersold R. Range of protein detection by selected/multiple reaction monitoring mass spectrometry in an unfractionated human cell culture lysate. Proteomics 12(8), 1185-1193 (2012
80. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide A ntibodies (SISCAPA). J. Proteome Res. 3(2), 235-244 (2004
81. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 9(1), 184-196 (2010
82. Kuhn E, Addona T, Keshishian H et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 55(6), 1108-1117 (2009
83. Kuhn E, Whiteaker JR, Mani DR et al. Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 11(6), M111 013854 (2012
84. Liu Y, Huttenhain R, Surinova S et al Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13(8), 1247-1256 (2013
85. Wang Q, Chaerkady R, Wu J et al. Mutant proteins as cancer-specific biomarkers. Proc. Natl Acad. Sci. USA 108(6), 2444-2449 (2011
86. Makridakis M, Vlahou A. Secretome proteomics for discovery of cancer biomarkers. J. Proteomics 73(12), 2291-2305 (2010
87. Luo X, Liu Y, Wang R, Hu H, Zeng R, Chen H. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer. J. Proteomics 74(4), 528-538 (2011
88. Liu Y, Luo X, Hu H et al. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer. PloS one 7(12), e51748 (2012
89. Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH. Too many roads not taken. Nature 470(7333), 163-165 (2011
90. Whiteaker JR, Lin C, Kennedy J et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29(7), 625-634 (2011
91. Addona TA, Shi X, Keshishian H et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 29(7), 635-643 (2011
92. Latterich M, Schnitzer JE. Streamlining biomarker discovery. Nat. Biotechnol. 29(7), 600-602 (2011
93. Geiger T, Cox J, Ostasiewicz P, Wisniewski JR, Mann M. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 7(5), 383-385 (2010
94. Li J, Su Z, Ma ZQ et al. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Mol. Cell. Proteomics 10(5), M110 006536 (2011
95. Sheynkman GM, Shortreed MR, Frey BL, Smith LM. Discovery and mass spectrometric analysis of novel splice-junction peptides using RNA-Seq. Mol. Cell. Proteomics 12(8), 2341-2353 (2013
96. Ostasiewicz P, Zielinska DF, Mann M, Wisniewski Jr. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J. Proteome Res. 9(7), 3688-3700 (2010
97. Pham TV, Piersma SR, Oudgenoeg G, Jimenez CR. Label-free mass spectrometry-based proteomics for biomarker discovery and validation. Expert Rev. Molecular Diagn. 12(4), 343-359 (2012
98. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1(5), 376-386 (2002
99. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3(12), 1154-1169 (2004
100. Plumb RS, Johnson KA, Rainville P et al. UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun. Mass Spectrom. 20(13), 1989-1994 (2006